user

Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

被引：0
|
作者：
Suzuki, Sho [1 ,2 ]
Ishibashi, Fumiaki [1 ,2 ]
Gotoda, Takuji [3 ]
机构：
[1] Int Univ Hlth, Dept Gastroenterol, Ichikawa, Japan
[2] Welf Ichikawa Hosp, Ichikawa, Japan
[3] Nihon Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2023年 / 62卷 / 16期
关键词：
Helicobacter pylori; clarithromycin resistance; penicillin allergy; vonoprazan; THERAPY;
D O I：
10.2169/internalmedicine.1282-22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2299 / 2300
页数：2
相关论文
共 50 条
  • [21] The Efficacy and Safety of Vonoprazan-Based Regimens for Helicobacter pylori Eradication Treatment: A Systemic Review and Network Meta-Analysis
    Zhang, Cangui
    Lu, Bingyun
    Xie, Li
    Ran, Xi
    Chen, Ye
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1671 - S1671
  • [22] Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature
    Hiroki Tanabe
    Katsuyoshi Ando
    Kiichi Sato
    Takahiro Ito
    Mitsuru Goto
    Tomonobu Sato
    Akihiro Fujinaga
    Toru Kawamoto
    Tatsuya Utsumi
    Nobuyuki Yanagawa
    Eiichiro Ichiishi
    Takaaki Otake
    Yutaka Kohgo
    Yoshiki Nomura
    Nobuhiro Ueno
    Hiroko Sugano
    Shin Kashima
    Kentaro Moriichi
    Mikihiro Fujiya
    Toshikatsu Okumura
    Digestive Diseases and Sciences, 2017, 62 : 3069 - 3076
  • [23] Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature
    Tanabe, Hiroki
    Ando, Katsuyoshi
    Sato, Kiichi
    Ito, Takahiro
    Goto, Mitsuru
    Sato, Tomonobu
    Fujinaga, Akihiro
    Kawamoto, Toru
    Utsumi, Tatsuya
    Yanagawa, Nobuyuki
    Ichiishi, Eiichiro
    Otake, Takaaki
    Kohgo, Yutaka
    Nomura, Yoshiki
    Ueno, Nobuhiro
    Sugano, Hiroko
    Kashima, Shin
    Moriichi, Kentaro
    Fujiya, Mikihiro
    Okumura, Toshikatsu
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (11) : 3069 - 3076
  • [24] EFFICACY AND SAFETY OF VONOPRAZAN-BASED TRIPLE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN 890 PATIENTS
    Akashi, Taro
    Fukuda, Daisuke
    Fukuda, Yutaka
    Akazawa, Yuko
    Nakao, Kazuhiko
    GASTROENTEROLOGY, 2017, 152 (05) : S249 - S250
  • [25] Vonoprazan-based Dual Therapy and Vonoprazan-based Triple Therapy for H. pylori Eradication: A Comparison of the Available Data
    Gatta, Luigi
    Malfertheiner, Peter
    Scarpignato, Carmelo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S637 - S637
  • [26] INEFFECTIVENESS OF 14-DAY VONOPRAZAN-BASED DUAL THERAPY AND VONOPRAZAN-BASED TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN AREA OF HIGH CLARITHROMYCIN RESISTANCE: A PROSPECTIVE RANDOMIZED STUDY
    Sanglutong, Likhasit
    Aumpan, Natsuda
    Pornthisarn, Bubpha
    Chonprasertsuk, Soonthorn
    Siramolpiwat, Sith
    Bhanthumkomol, Patommatat
    Kanokwanvimol, Amornnivit
    Nunanan, Pongjarat
    Mahachai, Varocha
    Vilaichone, Ratha-Korn
    GASTROENTEROLOGY, 2020, 158 (06) : S571 - S571
  • [27] Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication
    Jung, Y. S.
    Kim, E. H.
    Park, C. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (02) : 106 - 114
  • [28] Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan
    Howden, Colin W. W.
    Cook, Erin E. E.
    Swallow, Elyse
    Yang, Karen
    Guo, Helen
    Pelletier, Corey
    Jacob, Rinu
    Sugano, Kentaro
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [29] Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection
    Shinmura, Tetsuya
    Adachi, Kazunori
    Yamaguchi, Yoshiharu
    Izawa, Shinya
    Hijikata, Yasutaka
    Ebi, Masahide
    Funaki, Yasushi
    Ogasawara, Naotaka
    Sasaki, Makoto
    Kasugai, Kunio
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (04) : 389 - 395
  • [30] Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori
    Mori, Naoyoshi
    Nishiura, Yuuki
    Suga, Daisuke
    Moritani, Isao
    Yamanaka, Yutaka
    Ooya, Yumi
    Inoue, Hidekazu
    Takase, Koujirou
    Hioki, Masato
    Shiraki, Katsuya
    BIOMEDICAL REPORTS, 2018, 9 (02) : 169 - 174
12345